Skin Testing of Guinea Pigs and Footpad Testing of Mice with a New Antigen for Detecting Delayed Hypersensitivity to Cryptococcus Neoformans

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1974 Feb 1

PMID 4593343

Citations 22

Authors

J W Murphy

J A Gregory

H W LARSH

Affiliations

Soon will be listed here.

Abstract

This study was undertaken to evaluate the potential of a cryptococcal culture filtrate antigen, cryptococcin C184, for detecting delayed hypersensitivity in Cryptococcus neoformans-injected animals. The antigen was tested on guinea pigs which had received saline or C. neoformans and on animals sensitized to Histoplasma capsulatum, Blastomyces dermatitidis, Candida albicans, or Sporothrix schenckii. A delayed-type hypersensitivity response was elicited by cryptococcin C184 in C. neoformans-injected guinea pigs, whereas no indurations or erythemas were seen at 48 h after skin testing of saline controls or heterologously sensitized guinea pigs. Besides being specific for Cryptococcus, the antigen showed a high degree of sensitivity and was reproducible. Footpad tests were conducted with the antigen on mice which had previously received either 10(5) viable C. neoformans cells or saline. Delayed hypersensitivity was indicated in the C. neoformans-injected mice by the increase in thickness of antigen-injected footpads when compared with the saline-injected footpads. In control mice, antigen- and saline-injected footpads were comparable in thickness 24 h after injection. Mice sensitized to B. dermatitidis were footpad tested with C184, and no cross-reactivity was demonstrated.

Citing Articles

Current Models to Study the -Host Interaction.

Vargas-Macias A, Gomez-Gaviria M, Garcia-Carnero L, Mora-Montes H Front Fungal Biol. 2023; 3:833111.

PMID: 37746241 PMC: 10512367. DOI: 10.3389/ffunb.2022.833111.

The Cryptococcus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice.

Mandel M, Grace G, Orsborn K, Schafer F, Murphy J, Orbach M Infect Immun. 2000; 68(11):6196-201.

PMID: 11035725 PMC: 97699. DOI: 10.1128/IAI.68.11.6196-6201.2000.

Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans.

Murphy J, Schafer F, Casadevall A, Adesina A Infect Immun. 1998; 66(6):2632-9.

PMID: 9596727 PMC: 108249. DOI: 10.1128/IAI.66.6.2632-2639.1998.

Extracellular proteins of Cryptococcus neoformans and host antibody response.

Chen L, Pirofski L, Casadevall A Infect Immun. 1997; 65(7):2599-605.

PMID: 9199426 PMC: 175368. DOI: 10.1128/iai.65.7.2599-2605.1997.

History of medical mycology in the united states.

Espinel-Ingroff A Clin Microbiol Rev. 1996; 9(2):235-72.

PMID: 8964037 PMC: 172892. DOI: 10.1128/CMR.9.2.235.

References

Murphy J, COZAD G . Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun. 1972; 5(6):896-901. PMC: 422459. DOI: 10.1128/iai.5.6.896-901.1972. View

NEILL J, Abrahams I, KAPROS C . A comparison of the immunogenicity of weakly encapsulated and of strongly encapsulated strains of Cryptococcus neoformans (Torula histolytica). J Bacteriol. 1950; 59(2):263-75. PMC: 385749. DOI: 10.1128/jb.59.2.263-275.1950. View

Atkinson Jr A, Bennett J . Experience with a new skin test antigen prepared from Cryptococcus neoformans. Am Rev Respir Dis. 1968; 97(4):637-43. DOI: 10.1164/arrd.1968.97.4.637. View

SHAW L, HOWELL Jr A, Weiss E . Biological assay of lots of histoplasmin and the selection of a new working lot. Public Health Rep (1896). 1950; 65(18):583-609. PMC: 1997061. View

SALVIN S, Smith R . An antigen for detection of hypersensitivity to Cryptococcus neoformans. Proc Soc Exp Biol Med. 1961; 108:498-501. DOI: 10.3181/00379727-108-26977. View

Abrahams I . Further studies on acquired resistance to murine cryptococcosis: enhancing effect of Bordetella pertussis. J Immunol. 1966; 96(3):525-9. View

Nielsen Jr H . Biologic properties of skin test antigens of yeast form Sporotrichum schenckii. J Infect Dis. 1968; 118(2):173-80. DOI: 10.1093/infdis/118.2.173. View

Gentry L, Remington J . Resistance against Cryptococcus conferred by intracellular bacteria and protozoa. J Infect Dis. 1971; 123(1):22-31. DOI: 10.1093/infdis/123.1.22. View

ADAMSON D, COZAD G . Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans. J Bacteriol. 1969; 100(3):1271-6. PMC: 250312. DOI: 10.1128/jb.100.3.1271-1276.1969. View

10.

YOUMANS G, YOUMANS A . Allergenicity of mycobacterial ribosomal and ribonucleic acid preparations in mice and guinea pigs. J Bacteriol. 1969; 97(1):134-9. PMC: 249562. DOI: 10.1128/jb.97.1.134-139.1969. View

11.

Martins A, RAFFEL S . CELLULAR ACTIVITIES IN HYPERSENSITIVE REACTIONS. I. COMPARATIVE CYTOLOGY OF DELAYED, "JONES-MOTE" AND ARTHUS REACTIONS. J Immunol. 1964; 93:937-47. View

12.

Goodman N, Spouse R, LARSH H . Histoplasmin potency as affected by culture age. Sabouraudia. 1968; 6(4):273-84. DOI: 10.1080/00362176885190551. View

13.

HOTTLE G, Workman W . Standardization of histoplasmin. Public Health Monogr. 1956; 39:221-4. View

14.

SALVIN S, Youngner J, Lederer W . Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. Infect Immun. 1973; 7(1):68-75. PMC: 422640. DOI: 10.1128/iai.7.1.68-75.1973. View

15.

Spencer H, COZAD G . Role of delayed hypersensitivity in blastomycosis of mice. Infect Immun. 1973; 7(3):329-34. PMC: 422679. DOI: 10.1128/iai.7.3.329-334.1973. View

16.

MUCHMORE H, FELTON F, SALVIN S, RHOADES E . Delayed hypersensitivity to cryptococcin in man. Sabouraudia. 1968; 6(4):285-8. DOI: 10.1080/00362176885190561. View